Mind Medicine Inc., a leading biotech company developing psychedelic-inspired therapies, announced the initiation of Phase 2a proof-of-concept (POC) trial of lysergic acid diethylamide (LSD)...
Univar Solutions Inc. ("Univar Solutions" or "the Company"), a global chemical and ingredient distributor and provider of value-added services, announced a new agreement with...
BioLife Solutions, Inc., a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today...
Evofem Biosciences, Inc. and Orion Biotechnology Canada Ltd. announced that they have entered into a collaboration agreement to evaluate the compatibility and stability of...
